Lindy Biosciences is a development-stage protein therapeutic formulations company. Our core technology, Microglassification™, produces spherical, dense, stable particles of a therapeutic protein. These protein particles are ideal for long-term storage, or for incorporation into drug delivery formulations such as suspensions(for high-concentration delivery of antibodies), encapsulation (for sustained/controlled release), or dry powder pulmonary delivery.
View Top Employees from Lindy Biosciences, Inc.Website | http://www.lindybio.com |
Revenue | $3 million |
Funding | $1.6 million |
Employees | 15 (11 on RocketReach) |
Founded | 2017 |
Address | 100 Capitola Dr Ste 275, Durham, North Carolina 27713, US |
Phone | (919) 748-4480 |
Technologies |
JavaScript,
HTML,
Twitter
+10 more
(view full list)
|
Industry | Research Services, Business Services General, Biotechnology, Business Services, Science and Engineering, Product Research, Data and Analytics, Design, Therapeutics, Health Care |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 541714 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies |
Looking for a particular Lindy Biosciences, Inc. employee's phone or email?
The Lindy Biosciences, Inc. annual revenue was $3 million in 2024.
John Savage is the Director Research and Development of Lindy Biosciences, Inc..
11 people are employed at Lindy Biosciences, Inc..
Lindy Biosciences, Inc. is based in Durham, North Carolina.
The NAICS codes for Lindy Biosciences, Inc. are [541714, 5417, 54171, 541, 54].
The SIC codes for Lindy Biosciences, Inc. are [87, 873].